Log in to save to my catalogue

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting th...

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa50a0043fe4374a289804eeb9b41f1

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons

About this item

Full title

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2021-05, Vol.19 (1), p.141-15, Article 141

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The incidence of ischemic stroke in the context of vascular disease is high, and the expression of growth-associated protein-43 (GAP43) increases when neurons are damaged or stimulated, especially in a rat model of middle cerebral artery occlusion/reperfusion (MCAO/R).
DESIGN: We bioengineered neuron-targeting exosomes (Exo) conjugated to a mono...

Alternative Titles

Full title

Surface-modified engineered exosomes attenuated cerebral ischemia/reperfusion injury by targeting the delivery of quercetin towards impaired neurons

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5fa50a0043fe4374a289804eeb9b41f1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa50a0043fe4374a289804eeb9b41f1

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-021-00879-4

How to access this item